
Sanofi has announced new Phase III data for its IGlarLixi combination drug for the treatment of diabetes, showing it could …

There was unfortunate news for Sanofi and Zealand Pharma as the FDA announced that it required additional information, constituting a …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

